Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Sexually Transmitted Diseases (STD) specialty page provides STD-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


ATLAS-2M: Positive Top-Line Results for Long Acting Cabotegravir + Rilpivirine
The study has achieved its primary objective, demonstrating that administration every 8 weeks is as effective in maintaining viral suppression compared with monthly administration.
Vaginal Microbiome May Protect Women From Chlamydia
Lactic acid produced by bacteria in the vagina may help protect women from Chlamydia trachomatis infection, a new study suggests.
First Phase 1 Trial of Chlamydia Vaccine Candidate Shows Promising Results
The vaccine was based on a recombinant protein subunit (CTH522) and evaluated in a prime-boost immunization schedule.
Youth Born With HIV Face Unique Challenges
Transitioning from a child born with HIV into an adult living with HIV often means less adherence to antiretroviral medication therapies and a lower level of viral suppression. A new study delves into some possible reasons why.
Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects
There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
Preclinical Trial of TDF Vaginal Ring for PrEP Ends Early
Research on a tenofovir disoproxil fumarate intravaginal ring for PrEP hit a hurdle when 8 of 12 women unexpectedly developed vaginal ulcers.
An 'Achilles Heel' for Gonorrhea Infection?
Blocking the transport of critical metals like zinc into the cell could be a way to prevent growth and therefore infection by Neisseria gonorrhoeae.
FDA Panel Recommends F/TAF for PrEP in MSM and Transgender Women
The committee voted 16 to 2 to recommend F/TAF for PrEP based upon data from the phase 3 DISCOVER study, which evaluated F/TAF in comparison with F/TDF.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?